.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Mallinckrodt
Daiichi Sankyo
Citi
Fuji
Cipla
Johnson and Johnson
AstraZeneca
Argus Health
Accenture

Generated: December 15, 2017

DrugPatentWatch Database Preview

IMIPRAMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Imipramine Hydrochloride, and what generic alternatives are available?

Imipramine Hydrochloride is a drug marketed by Novartis, Leading Pharma Llc, Lederle, Lupin Ltd, Mallinckrodt Inc, Oxford Pharms, Par Pharm, Roxane, Sandoz, Sun Pharm Industries, Teva, Usl Pharma, Vangard, Watson Labs, and West Ward. and is included in thirty-six NDAs.

The generic ingredient in IMIPRAMINE HYDROCHLORIDE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
Drug patent expirations by year for IMIPRAMINE HYDROCHLORIDE

Pharmacology for IMIPRAMINE HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Watson LabsIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL085875-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm IndustriesIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL081050-001Jun 5, 1990ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL085877-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL084937-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL083729-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL085133-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
NovartisIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideCONCENTRATE;ORAL086765-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL088262-001Oct 21, 1983ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL084936-002Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
VangardIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL087631-001Jan 4, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Healthtrust
Merck
Farmers Insurance
Accenture
McKesson
Cipla
US Department of Justice
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot